Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo Controlled Phase II Cross Over Study on the Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress

NCT02904109 is registered in ClinicalTrials.gov with Prof. Dominique de Quervain, MD as lead sponsor.

NCT NCT02904109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02904109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo Controlled Phase II Cross Over Study on the Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress
Lead sponsor
Prof. Dominique de Quervain, MD
Phase
Phase 2
Overall status
Completed
Start date
September 13, 2016
Completion date
February 28, 2017
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy